UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
CURRENT REPORT
FORM 8-K
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
Date of Report (Date of Earliest Event Reported): May 14, 2015
Hanger, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
1-10670 |
|
84-0904275 |
(State or other jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer Identification |
10910 Domain Drive, Suite 300
Austin, Texas 78758
(Address of principal executive offices (zip code))
(512) 777-3800
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a - 12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Hanger, Inc. (the Company) announced that on May 14, 2015 the Companys Board of Directors (the Board) elected Cynthia L. Lucchese as a director of the Company to serve until the 2015 annual meeting of stockholders of the Company and until her successor is elected and qualified.
Ms. Lucchese is the Chief Administrative Officer and Chief Financial Officer of Hulman & Company, a privately held company headquartered in Indianapolis, Indiana, which owns and operates the Indianapolis Motor Speedway, INDYCAR racing league, Indianapolis Motor Speedway Productions, Clabber Girl Corporation and various real estate holdings. Prior to joining Hulman, Ms. Lucchese was Senior Vice President and Chief Financial Officer of Hillenbrand, Inc., where from 2008 to 2014 she was a key member of the leadership team that transformed Hillenbrand from a $650 million North American business to a $1.6 billion global diversified industrial company. She also has extensive experience in the medical device industry, including serving from 2005 to 2007 as Senior Vice President and Chief Financial Officer of Thoratec Corporation, a medical device company focused on treating advanced stage heart failure. Ms. Lucchese also held various senior financial positions with Guidant Corporation, now a part of Boston Scientific Corporation, from 1994 to 2005, including Vice President and Treasurer, Vice President Finance and Administration, and Vice President - Controller and Chief Accounting Officer. Earlier in her career, Ms. Lucchese held various roles at Eli Lilly & Company and Ernst & Young. She has served on the board of Intersect ENT, Inc. since July 2014, including as Chairman of the Audit Committee and a member of the Nominating and Corporate Governance Committee. Ms. Lucchese served on the Board of Brightpoint, Inc., including as Chairman of the Audit Committee and a member of the Nominating and Corporate Governance Committee, from 2009 until the sale of Brightpoint to Ingram Micro in 2012. She currently also serves as a member of the Deans Council for the Kelley School of Business of Indiana University.
Ms. Lucchese, a Certified Public Accountant, earned a bachelors degree in accounting and a masters degree in business administration from Kelley School of Business of Indiana University.
As a non-employee director, Ms. Lucchese will be compensated in accordance with the Companys compensation policies for non-employee directors, which are as described in the Companys 2014 proxy statement filed with the Securities and Exchange Commission. Upon her election to the Board, Ms. Lucchese is entitled to receive the annual cash retainer and annual equity award payable to the directors each year..
There is no arrangement or understanding between Ms. Lucchese and any other person pursuant to which Ms. Lucchese was elected as a director of the Company, and there are no transactions in which Ms. Lucchese has an interest requiring disclosure under Item 404(a) of Regulation S-K. Ms. Lucchese has not yet been appointed to serve as a member of any committee of the Board.
Ms. Lucchese was elected by the Board to fill a vacancy created by the Board when it increased the size of its Board from nine to ten directors pursuant to its authority to determine the size of the Board by resolution granted to it under the Amended and Restated By-Laws of the Company.
The Company issued on May 18, 2015 a press release announcing Ms. Luccheses election to the Board, which press release is filed herewith as Exhibit 99.1.
On May 15, 2015, the Board rotated the assignment of directors to the various committees of the Board (each, a Committee), with the new Committee assignments effective immediately. The new Committee assignments are as follows:
· Corporate Governance and Nominating Committee: Christopher Begley (Chair), Thomas Cooper, MD, Richard Pettingill and Patricia Shrader.
· Compensation Committee: Asif Ahmad, Thomas Cooper, MD (Chair), Cynthia Feldmann and Eric Green.
· Audit Committee: Christopher Begley, Cynthia Feldmann and Stephen Hare (Chair).
· Quality and Technology Committee: Asif Ahmad, Stephen Hare, Richard Pettingill (Chair) and Patricia Shrader.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press release of Hanger, Inc. issued on May 18, 2015.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HANGER, INC. |
| |
|
| |
|
| |
By: |
/s/ Thomas E. Hartman |
|
|
Thomas E. Hartman |
|
|
Vice President and General Counsel |
|
|
| |
Dated: May 18, 2015 |
|
Exhibit 99.1
Hanger Announces Appointment of Cynthia Lucchese to Board of Directors
AUSTIN, Texas, May 18, 2015 Hanger, Inc. (NYSE: HGR) today announced that its Board of Directors elected Cynthia L. Lucchese, former Senior Vice President and Chief Financial Officer of Hillenbrand, Inc. (NYSE: HI), to the Hanger Board as a Director effective May 14, 2015. Ms. Lucchese qualifies as an independent director under applicable New York Stock Exchange listing standards.
Cindy has an extensive depth of experience in financial accounting matters in health care businesses, Hanger President and CEO Vinit Asar said. When combined with her involvement on the audit committee of two public companies, her impressive background is an excellent fit for Hanger. She will bring valuable perspectives and insights to our Board of Directors as we continue to advance our financial operations.
During her tenure at Hillenbrand, Inc., Ms. Lucchese served as a key member of the leadership team that transformed the organization from a $650 million North American business to a $1.6 billion global diversified industrial company. She has extensive experience in the medical device industry, including having served as Senior Vice President and Chief Financial Officer of Thoratec Corporation, a company focused on treating advanced stage heart failure. Ms. Lucchese held various senior financial positions with Guidant Corporation, now a part of Boston Scientific Corporation, including Vice President and Treasurer, Vice President Finance and Administration, and Vice President Controller and Chief Accounting Officer. She is a Director of Intersect ENT, Inc. where she is Chair of the Audit Committee and a member of the Nominating and Corporate Governance Committee. She previously served on the board of Brightpoint, Inc., including as Chair of the Audit Committee and a member of the Nominating and Corporate Governance Committee. Ms. Lucchese is currently the Chief Administrative Officer and Chief Financial Officer of Hulman & Company, a privately held company headquartered in Indianapolis, Indiana, that owns and operates the Indianapolis Motor Speedway, INDYCAR racing league, Indianapolis Motor Speedway Productions, Clabber Girl Corporation, and various real estate holdings.
A Certified Public Accountant, Ms. Lucchese earned a bachelors degree in accounting and a masters degree in business administration from Kelley School of Business of Indiana University, where she currently serves as a member of the Deans Council.
About Hanger, Inc. Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hangers Patient Care segment is the largest owner and operator of O&P patient care clinics with in excess of 770 locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. Steeped in over 150 years of clinical excellence and innovation, Hangers vision is to be the partner of choice for products and services that enhance human physical capability. For more information on Hanger, visit www.hanger.com and follow us at www.Facebook.com/HangerNews, www.Twitter.com/HangerNews, and www.YouTube.com/HangerNews.
SOURCE Hanger, Inc.
Contact: Chris Brinzey, Westwicke Partners for Hanger, Inc., (512) 777-3690
###